We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Off-Center Fold |

Generalized Annular Bullous Eruption—Diagnosis

Arch Dermatol. 2011;147(1):109-114. doi:10.1001/archdermatol.2010.404-b.
Text Size: A A A
Published online


Dilling  ARose  CHashimoto  TZillikens  DShimanovich  I Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease. J Dermatol 2007;34 (1) 1- 8
PubMed Link to Article[[XSLOpenURL/10.1111/jde.2007.34.issue-1]]
Dainichi  TKurono  SOhyama  B  et al.  Anti-laminin gamma-1 pemphigoid. Proc Natl Acad Sci U S A 2009;106 (8) 2800- 2805
PubMed Link to Article[[XSLOpenURL/10.1073/pnas.0809230106]]
Zillikens  DKawahara  YIshiko  A  et al.  A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 1996;106 (3) 465- 470
PubMed Link to Article[[XSLOpenURL/10.1111/jid.1996.106.issue-3]]
Kawahara  YMatsuo  YHashimoto  TNishikawa  T A case of unique subepidermal blistering disease with autoantibodies against a novel dermal 200-kD antigen. Dermatology 1998;196 (2) 213- 216
PubMed Link to Article[[XSLOpenURL/10.1159/000017901]]
Watanabe  MTsunoda  TTagami  H A subepidermal blistering dermatosis associated with coexistent IgG and IgA anti-dermal basement membrane zone antibodies; demonstration of IgG antibodies reactive against a 200-kDa dermal antigen. Eur J Dermatol 2002;12 (6) 603- 606
Umemoto  NDemitsu  TToda  S  et al.  A case of anti-p200 pemphigoid clinically mimicking inflammatory epidermolysis bullosa acquisita. Br J Dermatol 2003;148 (5) 1058- 1060
PubMed Link to Article[[XSLOpenURL/10.1046/j.1365-2133.2003.05312.x]]
Domloge-Hultsch  NGammon  WRBriggaman  RAGil  SGCarter  WGYancey  KB Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest 1992;90 (4) 1628- 1633
PubMed Link to Article[[XSLOpenURL/10.1172/JCI116033]]
Chan  LSCooper  KD A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component. Arch Dermatol 1994;130 (3) 343- 347
PubMed Link to Article[[XSLOpenURL/10.1001/archderm.1994.01690030075012]]
Ghohestani  RFHudson  BGClaudy  AUitto  J The alpha 5 chain of type IV collagen is the target of IgG autoantibodies in a novel autoimmune disease with subepidermal blisters and renal insufficiency. J Biol Chem 2000;275 (21) 16002- 16006
PubMed Link to Article[[XSLOpenURL/10.1074/jbc.275.21.16002]]
Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections